Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus.

Greiling TM, Dehner C, Chen X, Hughes K, Iñiguez AJ, Boccitto M, Ruiz DZ, Renfroe SC, Vieira SM, Ruff WE, Sim S, Kriegel C, Glanternik J, Chen X, Girardi M, Degnan P, Costenbader KH, Goodman AL, Wolin SL, Kriegel MA.

Sci Transl Med. 2018 Mar 28;10(434). pii: eaan2306. doi: 10.1126/scitranslmed.aan2306.

PMID:
29593104
2.

Translocation of a gut pathobiont drives autoimmunity in mice and humans.

Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, Costa FRC, Tiniakou E, Greiling T, Ruff W, Barbieri A, Kriegel C, Mehta SS, Knight JR, Jain D, Goodman AL, Kriegel MA.

Science. 2018 Mar 9;359(6380):1156-1161. doi: 10.1126/science.aar7201. Erratum in: Science. 2018 May 4;360(6388):.

PMID:
29590047
3.

Modulation of Intestinal Microbiome Prevents Intestinal Ischemic Injury.

Bertacco A, Dehner CA, Caturegli G, D'Amico F, Morotti R, Rodriguez MI, Mulligan DC, Kriegel MA, Geibel JP.

Front Physiol. 2017 Dec 19;8:1064. doi: 10.3389/fphys.2017.01064. eCollection 2017.

4.

Self or non-self? The multifaceted role of the microbiota in immune-mediated diseases.

Kriegel MA.

Clin Immunol. 2015 Aug;159(2):119-21. doi: 10.1016/j.clim.2015.05.010. Epub 2015 May 21. No abstract available.

5.

Autoimmune host-microbiota interactions at barrier sites and beyond.

Ruff WE, Kriegel MA.

Trends Mol Med. 2015 Apr;21(4):233-44. doi: 10.1016/j.molmed.2015.02.006. Epub 2015 Mar 11. Review.

6.

The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome.

Ruff WE, Vieira SM, Kriegel MA.

Curr Rheumatol Rep. 2015 Jan;17(1):472. doi: 10.1007/s11926-014-0472-1. Review.

7.

Diet, microbiota and autoimmune diseases.

Vieira SM, Pagovich OE, Kriegel MA.

Lupus. 2014 May;23(6):518-26. doi: 10.1177/0961203313501401. Review.

8.

Sex-specific environmental influences on the development of autoimmune diseases.

Tiniakou E, Costenbader KH, Kriegel MA.

Clin Immunol. 2013 Nov;149(2):182-91. doi: 10.1016/j.clim.2013.02.011. Epub 2013 Feb 28. Review.

9.

Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha.

Lichtman EI, Helfgott SM, Kriegel MA.

Clin Immunol. 2012 Jun;143(3):210-21. doi: 10.1016/j.clim.2012.03.005. Epub 2012 Apr 6. Review.

10.

Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells.

Kriegel MA, Rathinam C, Flavell RA.

Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3457-62. doi: 10.1073/pnas.1115308109. Epub 2012 Feb 10.

11.

Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice.

Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, Mathis D.

Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11548-53. doi: 10.1073/pnas.1108924108. Epub 2011 Jun 27.

12.

Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Kriegel MA, Manson JE, Costenbader KH.

Semin Arthritis Rheum. 2011 Jun;40(6):512-531.e8. doi: 10.1016/j.semarthrit.2010.07.009. Epub 2010 Nov 2. Review.

13.

E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance.

Kriegel MA, Rathinam C, Flavell RA.

Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16770-5. doi: 10.1073/pnas.0908957106. Epub 2009 Sep 17.

14.

Sterile empyematous pleural effusion in a patient with systemic lupus erythematosus: a diagnostic challenge.

Kriegel MA, Van Beek C, Mostaghimi A, Kyttaris VC.

Lupus. 2009 Jun;18(7):581-5. doi: 10.1177/0961203309103049.

15.

Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy.

Kriegel MA, Adam-Klages S, Gabler C, Blank N, Schiller M, Scheidig C, Kalden JR, Lorenz HM.

Int Immunol. 2008 Apr;20(4):601-13. doi: 10.1093/intimm/dxn019. Epub 2008 Feb 28.

PMID:
18310062
16.

Interleukin-4 supports interleukin-12-induced proliferation and interferon-gamma secretion in human activated lymphoblasts and T helper type 1 cells.

Kriegel MA, Tretter T, Blank N, Schiller M, Gabler C, Winkler S, Kalden JR, Lorenz HM.

Immunology. 2006 Sep;119(1):43-53. Epub 2006 Jun 6.

17.

Transforming growth factor-beta: recent advances on its role in immune tolerance.

Kriegel MA, Li MO, Sanjabi S, Wan YY, Flavell RA.

Curr Rheumatol Rep. 2006 Apr;8(2):138-44. Review.

PMID:
16569373
18.

Lambert-Eaton myasthenic syndrome and undifferentiated connective tissue disease in a patient carrying the 8.1 ancestral haplotype.

Kriegel MA, Kalden JR, Lorenz HM.

Ann Rheum Dis. 2005 Jan;64(1):167-8. No abstract available.

19.

Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II.

Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR, Lorenz HM.

J Exp Med. 2004 May 3;199(9):1285-91. Epub 2004 Apr 26.

20.

Tumor necrosis factor receptor-associated periodic syndrome characterized by a mutation affecting the cleavage site of the receptor: implications for pathogenesis.

Kriegel MA, Hüffmeier U, Scherb E, Scheidig C, Geiler T, Kalden JR, Reis A, Lorenz HM.

Arthritis Rheum. 2003 Aug;48(8):2386-8. No abstract available.

Supplemental Content

Loading ...
Support Center